临床试验

Early Feasibility Study of 3930M Defibrillation Lead Implantation Via the Middle Cardiac Vein in Patients With Tricuspid Valve Regurgitation

NCT：NCT07811609 · NOT_YET_RECRUITING

NCT编号NCT07811609

状态NOT_YET_RECRUITING

SponsorMinneapolis Heart Institute Foundation (OTHER)

First posted2026-09-10

Last updated2026-09-10

简要摘要

Prospective, single center, early feasibility study designed to evaluate the initial safety and device performance of the Medtronic 3930M Lead when implanted via the Middle Cardiac Vein in patients with Tricuspid Valve Regurgitation

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。